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Kinin  B1 and B2 receptors  play  an essential  role  in  inﬂammatory  process  and  cardiovascular  homeostasis.
The  present  study  investigated  the  vascular  reactivity  and  nitric  oxide  (NO)  generation  in  the  isolated
mesenteric  arteriolar  bed  from  B1 (B1−/−)  and B2 receptor  (B2−/−) knockout  mice.  Endothelial-dependent
relaxation  was  signiﬁcantly  decreased  in  arterioles  from  both  B1−/− and  B2−/− in  comparison  to  wild
type  (WT)  mice,  with  no differences  for  endothelial-independent  relaxating  or vasoconstrictor  agents.
Plasmatic  and  vascular  NO  production  were  markedly  reduced  in  both  B1−/− and  B2−/−.  In contrast,
in  the  presence  of l-arginine,  Ca2+ and  co-factors  for the  enzyme,  NO synthase  activity  was  higher  in
homogenates  of  mesenteric  vessels  of  B1−/− and  B2−/−.  The  present  study  demonstrated  that  targetednockout
radykinin
ascular reactivity
itric  oxide
deletion  of  B1 or B2 receptor  gene  in  mice  induces  important  alterations  in  the  vascular  reactivity  of
resistance  vessels  and  NO  metabolism.  The  severe  impairment  in  the endothelial-mediated  vasodilation
accompanied  by  decreased  NO  bioavailability,  despite  the augmented  NOS  activity,  strongly  indicates  an
exacerbation  of  NO  inactivation  in  B1−/− and  B2−/− vessels.  The  present  data  provide  valuable  information
in  order  to clarify  the  relevance  of kinin  receptors  in regulating  vascular  physiology  and  may  point  to  new
 correapproaches  regarding  its
. Introduction
The kallikrein–kinin system plays an important role in several
iological functions, including inﬂammation and cardiovascular
omeostasis [7]. The diverse range of effects elicited by kinins is
ediated by activation of G protein-coupled receptors, named B1
nd B2. Bradykinin (BK) is the natural agonist of the B2 receptor,
nd its degradation by carboxypeptidases generates the B1 receptor
gonist, des-Arg[9]-BK [34]. Whereas B2 receptors are constitu-
ively expressed and mediate most of the known effects assigned
o kinins, B1 receptors are weakly detectable under physiological
onditions, but rapidly induced by inﬂammatory stimuli [7,23].
Both  B1 and B2 receptors act through Gq to stimulate phospho-
ipase C followed by phosphoinositide hydrolysis and intracellular
ree Ca2+ mobilization [19]. The resulting intracellular free Ca2+ is
he initial step in the activation of nitric oxide synthase (NOS),
hich catalyzes oxidation of the terminal guanidine nitrogen of
-arginine to form l-citrulline and nitric oxide (NO) [32]. Three
OS isoforms have been described: neuronal NOS (nNOS or NOS1),
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inducible NOS (iNOS or NOS2), and endothelial NOS  (eNOS or
NOS3). The iNOS isoform differs from nNOS and eNOS in that
it is fully active in the absence of Ca2+ [27]. The NOS  isoforms
have similar enzymatic mechanisms and require presence of
co-factors tetrahydrobiopterin (BH4), nicotinamide-adenine din-
ucleotide (NADPH), ﬂavin adenine dinucleotide (FAD) and ﬂavin
mononucleotide (FMN) for its proper function [25]. In the vascula-
ture, once formed by NOS, endothelial NO diffuses in to the smooth
muscle and activates soluble guanylate cyclase that catalyzes the
formation of 3′, 5′-cyclic guanosine monophosphate (cGMP), result-
ing in smooth muscle relaxation and therefore vasodilation [13].
In the last recent years, the development of genetically
engineered mice lacking kinin receptors has allowed a better
understanding of the physiological and pathological role of the
kallikrein–kinin system in a wide range of biological events [31].
Mice with a targeted deletion of the gene for the B1 receptor
(B1−/−) are described to be healthy, fertile and normotensive, but
exhibit blunted responses to bacterial lipopolysaccharide injec-
tion and hypoalgesia [30]. Under physiological conditions, B2
receptor knockout mice (B2−/−) present normal development [9],
Open access under the Elsevier OA license.renal hemodynamics and salt balance [2,26,35]. Nevertheless, data
regarding the effects of B2 receptor deletion on blood pressure reg-
ulation are controversial. Some authors have demonstrated that
B2−/− are normotensive [1–3,11,12,26,35,37,39] while other groups
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bserved a slight but signiﬁcant increase in blood pressure levels
15,16,21,22].
Considering that both B1 and B2 receptors are located in the
ndothelium and in vascular smooth muscle cells [7,19], and
hat resistance vessels are the most important sites for deter-
ining peripheral vascular resistance [38], the present study was
ddressed to investigate the vascular reactivity of mesenteric arte-
ioles of B1−/− and B2−/− in response to endothelium-dependent
nd  -independent agonists. In parallel, plasma NO levels, vascular
O release and NOS activity in the mesenteric vessels were also
nalyzed in order to provide information about NO bioavailability
n these mice strains.
.  Methods
.1. Animals
C57Bl/6 male knockout B1 (B1−/−), B2 (B2−/−) and wild type
WT) mice, aged 10–14 weeks were obtained from the breeding
tock of Centro de Desenvolvimento de Modelos Experimentais
ara Medicina e Biologia (CEDEME – UNIFESP). Mice were kept in a
emperature-controlled room on a 12 h light/day cycle, 60% humid-
ty, standard mice chow and water ad libitum. In B1−/− and B2−/−,
he absence of the kinins receptors was shown by undetectable
evel of mRNA encoding for the B1 or B2 receptor, respectively,
sing a semi-quantitative RT-PCR technique. All procedures were
pproved and performed in accordance with the guidelines of the
thics Committee of the UNIFESP (protocol number 0928/05), con-
ormed with the Guide for the Care and Use of Laboratory Animals
ublished by the US National Institutes of Health (NIH Publication
o. 85-23, revised 1996).
.2.  Vascular reactivity in the perfused mesenteric vascular bed
Isolated  mesenteric vascular beds were prepared as previously
escribed for the rat preparation [24], with slight adaptations for
he mouse. The mesenteric vascular bed was perfused with Krebs-
enseleit solution, pH 7.4, 37 ◦C, gassed with 95% O2 and 5% CO2,
t a constant rate of 2 mL/min using a peristaltic pump. Vascular
esponses were evaluated by changes in the perfusion pressure
mmHg) measured by a data acquisition system (PowerLab 8/S,
DInstruments Pty Ltda, Australia). To conﬁrm the viability of tis-
ues, preparations were perfused with KCl (90 mmol/L) added to
he Krebs solution for 5 min. After 30 min  of stabilization, increas-
ng doses of norepinephrine (NE) (5–100 nmol), acetylcholine (ACh)
0.1–10 nmol) and sodium nitroprusside (SNP) (0.1–10 nmol) were
njected in bolus, in a volume range of 30–100 L, with a 3-min
nterval between each dose. For ACh and SNP assays, preparations
ere pre-contracted with NE (10 mol/L) added to Krebs solution
nd vascular responses were calculated as percentage of contrac-
ion induced by NE.
.3.  Measurements of circulating NO levels
The plasma NO levels were evaluated by NO derivatives nitrate
nd nitrite, as previously described [28]. Blood samples were
ollected into EDTA-coated tubes and plasma was immediately sep-
rated by low-speed centrifugation (1500 × g). The concentration
f nitrate in blood was determined by chemiluminescence, elicited
y the reaction of NO with ozone after nitrate reduction with VCl3
aturated solution in 1 mol/L HCl, at 90 ◦C, using a NO analyzer
NOATM280 Sievers Instruments Inc., Boulder, CO, USA). Nitrite was
etermined after reduction with 1% KCl solution in glacial acetic
cid to convert nitrite to NO.2 (2011) 1700–1705 1701
2.4.  Basal NO production in mesenteric arterioles
Basal NO in mesenteric arterioles was determined by using a
ﬂuorescent cell permeable dye for NO, 4,5 diaminoﬂuorescein diac-
etate (DAF-2 DA, Alexis, USA), as previously described [10]. Once
inside the cell, DAF-2 DA is hydrolyzed by cytosolic esterases thus
releasing DAF-2. The reaction between DAF-2 and NO yields the cor-
responding bright green-ﬂuorescent triazoloﬂuoresceins (DAF-2T).
The mesenteric arterioles were dissected, immersed in medium
for cryosectioning and cut into 10 m thick sections (Leica CM
1850 cryostat, Leica Instruments, Germany). In order to stimu-
late NOS activation and provide optimal levels of substrate, slices
were pre-incubated with phosphate buffer (PB) solution contain-
ing CaCl2 (0.45 mol/L) and l-arginine (100 mol/L) during 30 min
at 37 ◦C. Slices were washed, incubated with PB containing DAF-2
DA (10 mol/L) for 30 min  at 37 ◦C and observed on a micro-
scope (Axiovert 100 M – Carl Zeiss SMT, Germany) equipped with
ﬂuorescein ﬁlter (excitation at 488 nm and measuring emission
at 515 nm). Fluorescence emitted in response to NO production
was quantiﬁed through optic densitometry (arbitrary units, a.u.)
using the AxioVision 4.8. digital images analysis software (Carl
Zeiss). The semi-quantitative analysis of basal NO production was
determined, at least, in three slices from each animal. Signiﬁcant
auto-ﬂuorescence was  discarded by experiments performed in the
absence of DAF-2DA.
2.5.  Detection of NOS activity in the mesenteric vascular bed
NOS  activity was  measured by the biochemical conversion
of l-[3H] arginine to l-[3H] citrulline according to the method
described by Rees et al. [33]. Mesenteric vessels were dissected,
washed, homogenized in ice-cold buffer and stored at −80◦C. On
the day of assay, homogenates were incubated (37 ◦C/60 min) in
a buffer containing FMN  and FAD 4 mol/L, calmodulin 10 g/mL,
Ca2+ 1.25 mmol/L, NADPH 1 mmol/L, l-arginine 120 nmol/L, l-[3H]
arginine 50 nmol/L (NEN Life Science Products, USA) and BH4
10 mol/L. For the determination of iNOS activity, experiments
were performed in the absence of Ca2+. Reaction was terminated
by the addition of cation-exchange resin (Dowex 50WX8-400)
to remove the excess of substrate. The resin was  left to settle
for 30 min  at room temperature, the supernatant was carefully
removed in vials with scintillation liquid and the radioactivity
to l-[3H] citrulline was  quantiﬁed. Results were normalized by
protein concentration and NO synthase activity was expressed as
pmol/mg min.
2.6. Drugs and reagents
NE,  ACh and SNP were acquired from Sigma Chemical Co. (St.
Louis, MO). Except when described, all other drugs and reagents
were purchased from Merck, Sharp & Döhme (Whitehouse Station,
NJ).
2.7. Statistical analysis
Comparisons were made by ANOVA followed by Tukey–Kramer
test. Values were reported as mean ± standard error of mean (SEM).
Statistical signiﬁcance was set as P < 0.05.
3. Results
3.1. Vascular reactivity to NE, ACh and SNPAfter 30 min  of stabilization, basal perfusion pressure in mesen-
teric vascular bed from B2−/− (48 ± 1.8 mmHg; n = 8; P < 0.05) was
signiﬁcantly higher when compared to WT (40 ± 1.4 mmHg; n = 11)
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Fig. 1. (A) Representative recording of perfusion pressure alteration elicited by in
bolus injection of NE in the mice isolated mesenteric arteriolar bed. Arrows indicate
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Fig. 2. Bars graph shows the relaxating effect of ACh in isolated mesenteric arteriolar
bed  of WT,  B1−/− and B2−/− . Responses are expressed as % of contraction induced by
NE  (10 mol/L). Results are mean ± S.E.M., n = 5–7 for each group. *P < 0.05 vs WT.
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Vascular NO production was  assessed in mesenteric arterioles
sections incubated with DAF-2 DA, a sensitive ﬂuorescent indicator
for detection of NO. Images are shown in Fig. 5A. The ﬂuorescence
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 ]rug application. (B) Bars graph shows the vasoconstrictor effect of NE (determined
s  increase in perfusion pressure) on isolated mesenteric arteriolar bed of WT,  B1−/−
nd B2−/− . Results are mean ± S.E.M., n = 5–7 for each group.
nd B1−/− (41 ± 1.0 mmHg; n = 8) preparations. Injection of vaso-
onstrictor NE on isolated vascular preparations elicited rapid and
ose-related constriction that increased to a single peak and then
eclined to basal perfusion pressure, usually within 2 min (Fig. 1A).
E injection promoted similar responses in all vascular prepara-
ions from WT,  B1−/− and B2−/−, as demonstrated in Fig. 1B.
The  endothelial function of mesenteric arterioles was assessed
hrough the effect of ACh (an endothelium-dependent relaxating
gent) and SNP (an endothelium-independent relaxating agent) in
re-contracted vessels (NE 10 mol/L). In all experiments, ACh pro-
uced a signiﬁcant dose-dependent reduction in perfusion pressure
at the doses of 0.1, 1 and 10 nmols). As shown in Fig. 2, vascular
esponse to ACh was markedly reduced in B1−/− and B2−/− prepa-
ations when compared to WT  responses, for all tested doses. In
ll groups, SNP injection elicited a consistent decrease in perfusion
ressure (about 60% of contraction induced by NE perfusion at the
ose of 10 nmols). No signiﬁcant differences were detected among
trains for all tested doses of SNP (Fig. 3).
.2. Plasmatic NO levels
Since  the NO metabolites reﬂect the overall NO production in
he organism, we determined the plasma nitrite/nitrate concentra-
ion in blood samples obtained from WT,  B1−/− and B2−/− mice. A
igniﬁcant decrease in circulating NO levels was detected in both
1
−/− and B2−/− when compared to WT  samples. Data are shown
n Fig. 4.Fig. 3. Bars graph shows the relaxating effect of SNP in isolated mesenteric arteriolar
bed  of WT,  B1−/− and B2−/− . Responses are expressed as % of contraction induced by
NE  (10 mol/L). Results are mean ± S.E.M., n = 6–7 for each group.
3.3. Basal NO production in mesenteric arteriolesWT B1
-/- B2
-/-
Fig. 4. Bars graph shows the NO plasma levels of WT,  B1−/− and B2−/− . Results are
mean  ± S.E.M., n = 4–5 for each group. *P < 0.05 vs WT.
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Fig. 5. (A) Representative images of ﬂuorescence in mesenteric arterioles slices from WT,  B1−/− and B2−/− after incubation with DAF-2DA (10 mol/L), a ﬂuorescent cell
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eermeable dye for NO (200×magniﬁcation). (B) Bars graph shows the ﬂuorescence em
as  quantiﬁed by optic densitometry (arbitrary units, a.u.). Results are mean ± S.E.M
ntensity of DAF-2 DA was signiﬁcantly diminished in vessels from
1
−/− and B2−/− when compared to WT  samples, indicating that
asal NO production was decreased in mesenteric arterioles from
oth strains (Fig. 5B).
.4.  NOS activity in mesenteric vessels
The NOS activity was assessed in homogenates of mesenteric
essels by biochemical conversion of l-[3H] arginine to l-[3H] cit-
ulline in presence of substrate and co-factors. Surprisingly, instead
f the expected reduction, total NOS activity (Ca2+-dependent) was
nhanced in mesenteric vessels from B1−/− and B2−/− when com-
ared with WT  samples, as represented in Fig. 6. The increase of NOS
ctivity in vessels from B1−/− and B2−/− probably is attributed to
ncrease in activity of eNOS or nNOS, since experiments performed
n absence of Ca2+ to determine iNOS activity (Ca2+-independent)
howed similar results among strains.
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ig. 6. Bars graph shows the NOS activity in presence or absence of Ca2+ to evalu-
te  total NOS activity and inducible NOS activity, respectively, in homogenates of
esenteric vessels from WT,  B1−/− and B2−/− . Results are mean ± S.E.M., n = 4–5 for
ach  group. *P < 0.05 vs WT. after incubation with DAF-2DA and represent the basal NO production. Fluorescence
 5 for each group. *P < 0.05 vs WT.
4. Discussion
The advent of potent and selective B1 and B2 receptor antago-
nists has permitted to assess the role of kinins in several biological
systems; however, receptor antagonists are not devoid of unspeci-
ﬁcity. The recent development of genetically engineered mice
lacking the kinin B1 and B2 receptor has allowed the opportunity to
investigate the physiological role of the kallikrein–kinin system in
absence of pharmacological interventions. By analyzing the effect
of vasoactive agents in mesenteric arterioles and measuring cir-
culating and tissue NO production, we  ﬁnd several evidences that
targeted deletion of kinin B1 or B2 receptor impairs endothelium-
mediated vasodilation by reducing NO bioavailability.
Firstly, we  observed that B2−/− arterioles exhibit increase in
basal perfusion pressure in comparison to WT  and B1−/−. Although
most of the studies have reported that B2−/− are normotensive
[1–3,11,12,26,35,37,39],  these mice appear to exhibit exaggerated
responses to hypertensive stimuli [3,11,12,15,20,21]. Thus, even
without an essential role in blood pressure regulation, B2 recep-
tor is clearly related to modulation of vascular tonus and control of
regional blood ﬂow to the organs.
Considering that vasodilation induced by ACh is directly depen-
dent on endothelial NO release [17] and that relaxating effect of
SNP is attributed to direct NO delivery on the smooth muscle [8],
our results demonstrate a severe impairment in the endothelial NO
– dependent vasodilation in mesenteric arterioles from both B1−/−
and B2−/−. This ﬁnding is in agreement with previous data showing
that the vasodepressor response to injection of ACh was shifted to
the right in B2−/− [2]. In the present study, we demonstrated for the
ﬁrst time that impaired vascular response to ACh is also present in
the B1−/− mice.
Contrasting in part with our results, a preserved response to
ACh in B2−/− mesenteric vessels has been previously related by
Berthiaume et al. [6]. This discrepant result can be explained by
marked differences in the methodology employed for vascular
reactive experiments. Indeed, studies in mice mesenteric vessels
have been performed under a wide range of ﬂow velocities,
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re-contracting agents, Krebs composition and enzymatic blockers
r other inhibitors added to the perfusion. In the present study,
ow velocity was chosen on the basis of its ability to induce a
ustained and sub-maximal vasoconstriction to NE (10 mol/L), in
he absence of other drugs. Vasodilator agents were tested in arte-
ioles submitted to an approximate 80 mmHg  increase in perfusion
ressure, and, in this case, ACh (10 nmol) evoked a vasodilation
round 12 mmHg, conﬁrming that preparations were able to
ilate.
In order to conﬁrm whether a possible impairment in NO
ioavailability in B1−/− and B2−/− could be responsible for the
educed ACh response, we analyzed plasmatic NO levels and vas-
ular NO generation in both strains. As expected, we observed
 signiﬁcant reduction on circulating NO levels and basal NO
elease in mesenteric arterioles from B1−/− and B2−/−. Similarly,
tudies have described lower nitrite/nitrate plasma levels [18]
nd reduced renal nitrite excretion [35] in B2−/− when com-
ared to WT  mice. Moreover, induced hypertension by chronic
O synthesis inhibition is less pronounced in B2−/− when com-
ared to WT  responses [20]. Therefore, B2 receptor deletion may
everely interfere with NO bioavailability. Our data show that,
esides B2, B1 receptors are also involved in basal and stimulated
O metabolism.
Reduction in NO levels can occur through several potential
echanisms, such as reduced NOS enzymatic activity or increased
O inactivation [29]. Considering that the bioavailability of NO
s largely dependent on NOS, we analyzed the NOS activity in
esenteric vessels by biochemical conversion of l-[3H] arginine
o l-[3H] citrulline in presence of substrate and co-factors. Sur-
risingly, instead of the expected reduction, total NOS activity
Ca2+-dependent) was elevated in homogenates of vessels from
1
−/− and B2−/−. These results are partially in agreement with Bar-
osa et al. [4], that observed a decrease in relaxating effect of SNP
n stomach fundus from B1−/−, despite increase in iNOS activity
nd cGMP levels. These ﬁndings indicate that, at least in presence
f supplementation with exogenous substrate and co-factors, NOS
rom both B1−/− and B2−/− is functional.
The  present data do not give support for explaining the contrast-
ng results about decreased NO levels accompanied by enhanced
OS activity in kinin knockout mice. One possible mechanism
esponsible for this could be the fact that uncoupling of NOS induces
OS-derived production of superoxide anion and hydrogen perox-
de [14,36]. In this case, reduced NO bioavailability in B1−/− and
2
−/− could be related to increase in vascular oxidative stress asso-
iated with elevated superoxide anion production and consequent
O inactivation. In fact, superoxide anion rapidly inactivates NO to
orm the highly reactive intermediate peroxynitrite, which repre-
ents a major potential pathway of NO reactivity and degradation
5,36]. Nevertheless, the generation of reactive oxygen species in
1
−/− and B2−/− mice has not yet been consistently analyzed and
urther studies will be required to test this hypothesis.
. Conclusion
In conclusion, the present study demonstrated that targeted
eletion of B1 or B2 receptor gene in mice induces important
lterations in the vascular reactivity of resistance vessels and NO
etabolism. The severe impairment in the endothelial-mediated
asodilation accompanied by decreased NO bioavailability, despite
he augmented NOS activity, strongly indicates an exacerbation of
O inactivation in B1−/− and B2−/−. The present data provide valu-
ble information in order to clarify the relevance of kinin receptors
n regulating vascular physiology and may  point to new approaches
egarding its correlation with endothelial dysfunction, oxidative
tress and NO availability.
[
[2 (2011) 1700–1705
Sources of funding
Supported by grants from Fundac¸ ão de Amparo à Pesquisa do
Estado de São Paulo (FAPESP 2007/59039-2, 2008/06676-8), Con-
selho Nacional de Desenvolvimento Cientíﬁco e Tecnológico (CNPq)
and Coordenac¸ ão de Aperfeic¸ oamento de Pessoal de Nível Superior
(CAPES).
References
[1] Abadir PM,  Carey RM,  Siragy HM.  Angiotensin AT2 receptor directly stim-
ulate renal nitric oxide in bradykinin B2 receptor null mice. Hypertension
2003;42:600–4.
[2] Alﬁe ME,  Yang XP, Hess JF, Carretero OA. Salt-sensitive hypertension in
bradykinin B2 receptor knockout mice. Biochem Biophys Res Commun
1996;224:625–30.
[3] Alﬁe ME, Sigmon DH, Pomposiello SI, Carretero OA. Effect of high salt intake in
mutant mice lacking bradykinin-B2 receptors. Hypertension 1997;29:483–7.
[4]  Barbosa AM,  Felipe SA, Araujo RC, Kawamoto EM,  Carvalho MHC, Scavone C,
et al. Altered reactivity of gastric fundus smooth muscle in the mouse with
targeted disruption of the kinin B1 receptor gene. Peptides 2009;30:901–5.
[5]  Beckman JS, Koppenol WH.  Nitric oxide, superoxide, and peroxynitrite: the
good, the bad, the ugly. Am J Physiol 1996;271:C1424–1437.
[6]  Berthiaume N, Hess F, Chen A, Regoli D, D’Orleans-Juste P. Pharmacology of
kinins in the arterial and venous mesenteric bed of normal and B2 knockout
transgenic mice. Eur J Pharmacol 1997;333:55–61.
[7]  Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kinino-
gens, and kininases. Pharmacol Rev 1992;44:1–80.
[8] Bonaventura D, Lunardi CN, Rodrigues GJ, Neto MA,  Bendhack LM.  A novel
mechanism of vascular relaxation induced by sodium nitroprusside in the iso-
lated rat aorta. Nitric Oxide 2008;18:287–95.
[9] Borkowski JA, Ransom RW,  Seabrook GR, Trumbauer M, Chen H, Hill RG, et al.
Targeted disruption of a B2 receptor gene in mice eliminates bradykinin action
in smooth muscle and neurons. J Biol Chem 1995;270:13706–10.
10]  Ceravolo GS, Fernandes L, Munhoz CD, Fernandes DC, Tostes RCA, Laurindo
FRM, et al. Angiotensin II chronic infusion induces B1 receptor expression in
aorta of rats. Hypertension 2007;50:756–61.
11] Cervenka L, Harrison-Bernard LM,  Dipp S, Primrose G, Imig JD, El-Dahr SS.
Early onset salt-sensitive hypertension in bradykinin B2 receptor null mice.
Hypertension 1999;34:176–80.
12] Cervenka L, Maly J, Karasova L, Simova M,  Vitko S, Hellerova S, et al. Angiotensin
II-induced hypertension in bradykinin B2 receptor knockout mice. Hyperten-
sion 2001;37:967–73.
13] Chen K, Popel AS. Theoretical analysis of biochemical pathways of nitric oxide
release from vascular endothelial cells. Free Radic Biol Med  2006;41:668–80.
14] Durante W,  Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide
synthesis and vascular function. Clin Exp Pharmacol Physiol 2007;34:906–11.
15] Emanueli C, Fink E, Milia AF, Salis MB, Conti M,  Demontis MP,  et al. Enhanced
blood pressure sensitivity to deoxycorticosterone in mice with disruption of
bradykinin B2 receptor gene. Hypertension 1998;31:1278–83.
16] Emmanueli C, Maestri R, Corradi D, Marchione R, Minasi A, Tozzi MG, et al.
Dilated and failing cardiomyopathy in badykinin B2 receptor knockout mice.
Circulation 1999;100:2359–65.
17] Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relax-
ation of arterial smooth muscle by acetylcholine. Nature 1980;27:373–6.
18] Kakoki M,  McGarrah RW,  Kim HS, Smithies O. Bradykinin B1 B2 recep-
tors both have protective roles in renal ischemia/reperfusion injury. PNAS
2007;104:7576–81.
19]  Leeb-Lundberg LM,  Marceau F, Müller-Esterl W,  Pettibone DJ, Zuraw BL. Inter-
national union of pharmacology XLV. Classiﬁcation of the kinin receptor family:
from molecular mechanisms to pathophysiological consequences. Pharmacol
Rev 2005;57:27–77.
20] Madeddu P, Varoni MV,  Palomba D, Emanueli C., Demontis MP,  Glorioso N, et al.
Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2
receptor gene. Circulation 1997;96:3570–8.
21] Madeddu P, Milia AF, Salis B, Gaspa L, Gross W,  Lippoldt A, et al. Renovas-
cular hypertension in bradykinin B2 receptor knockout mice. Hypertension
1998;32:503–9.
22] Maestri R, Milia AF, Salis MB,  Graiani G, Lagrasta C, Monica M,  et al. Cardiac
hypertrophy and microvascular deﬁcit in kinin B2 receptor knockout mice.
Hypertension 2003;41:1151–5.
23] Marceau F, Hess JF, Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev
1998;50:357–86.
24]  McGregor DD. The effect of the sympathetic nerve stimulation on vasocon-
strictor responses in perfused mesenteric blood vessels of the rat. J Physiol
1965;177:21–30.
25]  Michel T. Targeting and translocation of endothelial nitric oxide synthase. Br J
Med  Biol Res 1999;32:1361–6.26] Milia AF, Gross V, Plehm R, Silva Jr JA, Bader M, Luft FC. Normal blood pressure
and renal function in mice lacking the bradykinin B2 receptor. Hypertension
2001;37:1473–9.
27] Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related
to nitric oxide. FASEB 1995;9:1319–30.
Journal Identiﬁcation = PEP Article Identiﬁcation = 68412 Date: August 3, 2011 Time: 8:37 pm
tides 3
[
[
[
[
[
[
[
[
[
[
[R.A. Loiola et al. / Pep
28] Moriel P, Sevanian A, Ajzen S, Zanella MT,  Plavnik FL, Rubbo H, et al.
Nitric oxide, cholesterol oxides and endothelium-dependent vasodilation in
plasma of patients with essential hypertension. Braz J Med Biol Res 2002;35:
1301–9.
29]  Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the
development of vascular diseases. Arch Pharm Res 2009;32:1103–8.
30] Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva Jr JA, Walther T,
et al. Hypoalgesia and altered inﬂammatory responses in mice lacking kinin
B1 receptors. PNAS 2000;97:8140–5.
31]  Pesquero JB, Bader M.  Genetically altered animal models in the kallikrein–kinin
system. Biol Chem 2006;387:119–26.
32] Radomski MW,  Palmer RMJ, Moncada S. An l-arginine/nitric oxide pathway
present in human platelets regulates aggregation. PNAS 1990;87:5193–7.33] Rees D, Ben-Ishay D, Moncada S. Nitric oxide and the regulation of blood
pressure in the hypertension-prone and hypertension-resistant Sabra rat.
Hypertension 1996;97:1916–23.
34] Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol
Rev 1980;32:1–46.
[2 (2011) 1700–1705 1705
35] Schanstra JP, Duchene J, Praddaude F, Bruneval P, Tack I, Chevalier J, et al.
Decreased renal NO excretion and reduced glomerular tuft area in mice lacking
the bradykinin B2 receptor. Am J Physiol 2003;284:H1904–8.
36] Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T. Nitric oxide, tetrahy-
drobiopterin, oxidative stress, and endothelial dysfunction in hypertension.
Antioxid Redox Signal 2008;10:1115–26.
37] Trabold F, Pons S, Hagege AA, Bloch-Faure M,  Alhenc-Gelas F, Giudicelli JF,
et al. Cardiovascular phenotypes of kinin B2 receptor – and tissue kallikrein
– deﬁcient mice. Hypertension 2002;40:90–5.
38]  Vanhoutte PM,  Lüscher TF. Peripheral mechanism in cardiovascular regu-
lation: transmitters receptors and endothelium. In: Tarazi RC, Zanchetti A,
editors. Handbook of hypertension: physiology and pathophysiology of hyper-
tension: regulatory mechanisms. 18th ed. Amsterdan: Elservier Science; 1999.
p. 97–123.
39] Yang XP, Liu YH, Mehta D, Cavasin MA,  Shesely E, Xu J, et al. Diminished car-
dioprotective response to inhibition of angiotensin-converting enzyme and
angiotensin II type 1 receptor in B2 kinin receptor gene knockout mice. Circ
Res 2001;88:1072–9.
